Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2023-12-15 00:00:00 ET · period of report 2023-12-13 · accession 0001062993-23-022626 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-15 | 2023-12-13 | ADPT | NEUPERT PETER M | Dir | M - OptEx | $0.84 | +100.0K | 123.0K | +435% | +$84.0K |
| D | 2023-12-15 | 2023-12-13 | ADPT | NEUPERT PETER M | Dir | M - OptEx | $0.00 | -100.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-13 | M | A | 100,000 | $0.84 | 122,968 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2023-12-13 | M | D | 100,000 | $0.00 | 0 | D | $0.84 · — to 2023-12-23 | 100,000 Common Stock | (F1) The option vested with respect to 1/4 of the Shares under the grant on the year anniversary of December 23, 2013 and with respect to 1/48 of the Shares under the grant monthly thereafter. |